GLP1 RECEPTOR AGONISTS

Wegovy, Ozempic linked with sight-threatening eye disorder in study

After taking patients' other risk factors for the condition into account, such as high blood pressure and obstructive sleep apnea, use of semaglutide was associated with a more than four times higher risk of NAION in those receiving it for diabetes and a more than seven times higher risk in patients taking it for obesity.